General Info

Bracco, founded in 1927, is an integrated health care group, and is one of the world leaders in global solutions for the diagnostic imaging field. The company began as a pharmaceuticals trading concern, and has developed into an independent industrial production and research facility. It discovered and developed the iopamidol molecule, which is the first ready-to-use nonionic contrast medium. Bracco products cover all medical needs in cardiac, vascular, abdominal, and neuroimaging. It also markets key diagnostic imaging resources through various companies, including ACIST Medical Systems, a manufacturer of advanced contrast media injection systems and Volume Interactions, which produces advanced 3-D medical software. The company is headquartered in Princeton, N.J.